Welcome : Guest

Myriad Genetics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Myriad Genetics, Inc., which is principally involved in operating Specialty Molecular Diagnostic Laboratories. Illustrated with 47 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-04765
Price: $2350
Company Type: Public
Pages: 50
Date: April 2016
Market Data Tables: 47

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Myriad Genetics, Inc.’s Sales by Product Segment (2014-2015) in Percentage for Molecular Diagnostic Testing (MyRisk, BracAnalysis, VectraDA, Others), and Pharmaceutical and Clinical Services......3
Diagnostics Testing Services......4
Table 2: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......4
Table 3: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......5
Table 4: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......6
Table 5: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......7
Table 6: Diagnostic Testing Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......8
Table 7: Diagnostic Testing Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......9
Table 8: Diagnostic Testing Sales by Category in the US (2014) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......10
Table 9: Ambulatory Physician Diagnostics Testing Services Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, POLs, and Others......11
Table 10: Hospital Diagnostics Testing Services Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Outpatient, and Inpatient......12
Table 11: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......13
Clinical Laboratory Testing......14
Table 12: Clinical Laboratory Testing Market by Category in the US (2014) – Percentage Share Breakdown by Value Sales for Laboratory Corporation of America Holdings, Quest Medical, Inc., Physician Office, Hospital Affiliated, and Others......14
In Vitro Diagnostics (IVD) Laboratory Services......15
Table 13: In Vitro Diagnostics (IVD) Laboratory Services Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospital Labs, Independent Labs, Physician Office Labs, and Others......15
Table 14: In-Vitro Diagnostics (IVD) Laboratory Services Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospital Labs, Physician Office Labs, Other Independent Labs and Others......16
Table 15: In Vitro Diagnostics (IVD) Laboratory Market by Customer in France (2014) - Percentage Share Breakdown by Value Sales for Etablissement Français du Sang (EFS), Private Laboratories, Public and Private Hospitals, and Others......17
Molecular Diagnostics Laboratories......18
Table 16: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2014) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......18
Table 17: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2014) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......19
Table 18: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2014) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......20
Molecular Diagnostics......21
Table 19: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......21
Table 20: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2014) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......22
Table 21: Global Molecular Diagnostics (MDx) Market by Region (2014) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......23
Table 22: Molecular Diagnostic Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......24
Table 23: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......25
Table 24: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......26
Table 25: Molecular Diagnostics (MDx) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......27
Table 26: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......28
Table 27: Molecular Diagnostics (MoDx) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......29
Table 28: Molecular Diagnostics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......30
Table 29: Molecular Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......31
Table 30: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......32
Table 31: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......33
Table 32: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......34
Table 33: Molecular Diagnostics Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......35
Science Equipment and Laboratory Instruments......36
Table 34: Science Equipment and Laboratory Instruments Market Share by Region Worldwide (2015) - Percentage Breakdown by Value for China, Europe, Japan, USA and Canada, and Rest-of-World......36
Clinical Laboratories......37
Table 35: Market Shares of Leading Clinical Laboratories in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Physician Office Partners, Inc., Quest Diagnostics Incorporated, and Others......37
In Vitro Diagnostics (IVD) Laboratory Services......38
Table 36: Market Shares of Leading In Vitro Diagnostics (IVD) Laboratory Service Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Quest Diagnostics, Inc. (DGX), Laboratory Corporation of America Holdings (LH), Bio-Reference Laboratories, Inc. (BRLI), Myriad Genetics, Inc. (MYGN), and Others......38
Table 37: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others......39
Independent Laboratories......40
Table 38: Market Shares of Leading Independent Clinical Laboratory Service Providers in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Nichelabs, LLC, Quest Diagnostics Incorporated, and Others......40
Table 39: Market Shares of Leading Medicare Independent Laboratory Service Providers in the US (2015) - Percentage Breakdown by Value for Laboratory Corporation of America Holdings, Millennium Health, LLC, Quest Diagnostics, and Others......41
Cancer Genetic Diagnostics Reference Laboratories......42
Table 40: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......42
Molecular Diagnostics......43
Table 41: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......43
Table 42: Market Shares of Leading Molecular Diagnostics Providers Worldwide (2015) - Percentage Breakdown by Value for Abbott, Becton Dickinson, BioMerieux, Cepheid Inc, Hologic Corporation, Novartis International AG, Qiagen N.V., Roche Holding AG, Siemens AG, and Others......44
Table 43: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......45
Table 44: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......46
Diagnostic Testing......47
Table 45: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......47
Veterinary Laboratories......48
Table 46: Market Shares of Leading Veterinary Laboratories in the US (2014) - Percentage Breakdown by Value Sales for IDEXX Laboratories, Inc., Vca, Inc., and Others......48
Table 47: Myriad Genetics, Inc.’s Revenue by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for US and Rest of World......49